ORBIMED ADVISORS LLC 13D/13G Filings for scPharmaceuticals Inc. (SCPH)

ORBIMED ADVISORS LLC 13D and 13G filings for scPharmaceuticals Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-08-15
4:47 pm
Purchase		2024-08-1313DscPharmaceuticals Inc.
SCPH		ORBIMED ADVISORS LLC6,059,528
12.100%		500,000increase
(+8.99%)		Filing
2022-11-29
4:27 pm
Purchase		2022-11-2513DscPharmaceuticals Inc.
SCPH		ORBIMED ADVISORS LLC5,559,528
16.300%		762,380increase
(+15.89%)		Filing
2020-05-26
4:40 pm
Purchase		2020-05-2113DscPharmaceuticals Inc.
SCPH		ORBIMED ADVISORS LLC4,797,148
17.900%		1,387,283increase
(+40.68%)		Filing
2020-03-27
1:47 pm
Unchanged		2020-03-2413DscPharmaceuticals Inc.
SCPH		ORBIMED ADVISORS LLC3,409,865
16.300%		0
(Unchanged)		Filing